Viral Vectors and Plasmid DNA Manufacturing Market - Global Outlook and Forecast 2021-2027

Viral Vectors and Plasmid DNA Manufacturing Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Viral Vectors and Plasmid DNA Manufacturing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Viral Vectors and Plasmid DNA Manufacturing Overall Market Size
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size: 2021 VS 2027
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Viral Vectors and Plasmid DNA Manufacturing Players in Global Market
3.2 Top Global Viral Vectors and Plasmid DNA Manufacturing Companies Ranked by Revenue
3.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Companies
3.4 Top 3 and Top 5 Viral Vectors and Plasmid DNA Manufacturing Companies in Global Market, by Revenue in 2020
3.5 Global Companies Viral Vectors and Plasmid DNA Manufacturing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Viral Vectors and Plasmid DNA Manufacturing Players in Global Market
3.6.1 List of Global Tier 1 Viral Vectors and Plasmid DNA Manufacturing Companies
3.6.2 List of Global Tier 2 and Tier 3 Viral Vectors and Plasmid DNA Manufacturing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Viral Vectors and Plasmid DNA Manufacturing Market Size Markets, 2021 & 2027
4.1.2 Plasmid DNA
4.1.3 Viral Vectors
4.2 By Type - Global Viral Vectors and Plasmid DNA Manufacturing Revenue & Forecasts
4.2.1 By Type - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2021
4.2.2 By Type - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, 2022-2027
4.2.3 By Type - Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Viral Vectors and Plasmid DNA Manufacturing Market Size, 2021 & 2027
5.1.2 Cancers
5.1.3 Inherited Disorders
5.1.4 Viral Infections
5.1.5 Others
5.2 By Application - Global Viral Vectors and Plasmid DNA Manufacturing Revenue & Forecasts
5.2.1 By Application - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2021
5.2.2 By Application - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, 2022-2027
5.2.3 By Application - Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Viral Vectors and Plasmid DNA Manufacturing Market Size, 2021 & 2027
6.2 By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue & Forecasts
6.2.1 By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2021
6.2.2 By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, 2022-2027
6.2.3 By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2027
6.3.2 US Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.3.3 Canada Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.3.4 Mexico Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2027
6.4.2 Germany Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.4.3 France Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.4.4 U.K. Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.4.5 Italy Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.4.6 Russia Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.4.7 Nordic Countries Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.4.8 Benelux Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2027
6.5.2 China Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.5.3 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.5.4 South Korea Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.5.5 Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.5.6 India Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2027
6.6.2 Brazil Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.6.3 Argentina Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2027
6.7.2 Turkey Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.7.3 Israel Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.7.4 Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
6.7.5 UAE Viral Vectors and Plasmid DNA Manufacturing Market Size, 2016-2027
7 Players Profiles
7.1 BioReliance
7.1.1 BioReliance Corporate Summary
7.1.2 BioReliance Business Overview
7.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.1.4 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.1.5 BioReliance Key News
7.2 Cobra Biologics
7.2.1 Cobra Biologics Corporate Summary
7.2.2 Cobra Biologics Business Overview
7.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.2.4 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.2.5 Cobra Biologics Key News
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Corporate Summary
7.3.2 Oxford BioMedica Business Overview
7.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.3.4 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.3.5 Oxford BioMedica Key News
7.4 UniQure
7.4.1 UniQure Corporate Summary
7.4.2 UniQure Business Overview
7.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.4.4 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.4.5 UniQure Key News
7.5 FinVector
7.5.1 FinVector Corporate Summary
7.5.2 FinVector Business Overview
7.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.5.4 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.5.5 FinVector Key News
7.6 MolMed
7.6.1 MolMed Corporate Summary
7.6.2 MolMed Business Overview
7.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.6.4 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.6.5 MolMed Key News
7.7 MassBiologics
7.7.1 MassBiologics Corporate Summary
7.7.2 MassBiologics Business Overview
7.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.4.4 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.7.5 MassBiologics Key News
7.8 Richter-Helm
7.8.1 Richter-Helm Corporate Summary
7.8.2 Richter-Helm Business Overview
7.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.8.4 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.8.5 Richter-Helm Key News
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Corporate Summary
7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.9.4 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.9.5 FUJIFILM Diosynth Biotechnologies Key News
7.10 Lonza
7.10.1 Lonza Corporate Summary
7.10.2 Lonza Business Overview
7.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.10.4 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.10.5 Lonza Key News
7.11 Aldevron
7.11.1 Aldevron Corporate Summary
7.11.2 Aldevron Business Overview
7.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.11.4 Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.11.5 Aldevron Key News
7.12 Eurogentec
7.12.1 Eurogentec Corporate Summary
7.12.2 Eurogentec Business Overview
7.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.12.4 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.12.5 Eurogentec Key News
7.13 Cell and Gene Therapy Catapult
7.13.1 Cell and Gene Therapy Catapult Corporate Summary
7.13.2 Cell and Gene Therapy Catapult Business Overview
7.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.13.4 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.13.5 Cell and Gene Therapy Catapult Key News
7.14 Biovian
7.14.1 Biovian Corporate Summary
7.14.2 Biovian Business Overview
7.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.14.4 Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.14.5 Biovian Key News
7.15 Thermo Fisher Scientific (Brammer Bio)
7.15.1 Thermo Fisher Scientific (Brammer Bio) Corporate Summary
7.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
7.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.15.4 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.15.5 Thermo Fisher Scientific (Brammer Bio) Key News
7.16 VGXI
7.16.1 VGXI Corporate Summary
7.16.2 VGXI Business Overview
7.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.16.4 VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.16.5 VGXI Key News
7.17 PlasmidFactory
7.17.1 PlasmidFactory Corporate Summary
7.17.2 PlasmidFactory Business Overview
7.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Major Product Offerings
7.17.4 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (2016-2021)
7.17.5 PlasmidFactory Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Viral Vectors and Plasmid DNA Manufacturing Market Opportunities & Trends in Global Market
Table 2. Viral Vectors and Plasmid DNA Manufacturing Market Drivers in Global Market
Table 3. Viral Vectors and Plasmid DNA Manufacturing Market Restraints in Global Market
Table 4. Key Players of Viral Vectors and Plasmid DNA Manufacturing in Global Market
Table 5. Top Viral Vectors and Plasmid DNA Manufacturing Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Companies, 2016-2021
Table 8. Global Companies Viral Vectors and Plasmid DNA Manufacturing Product Type
Table 9. List of Global Tier 1 Viral Vectors and Plasmid DNA Manufacturing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Viral Vectors and Plasmid DNA Manufacturing Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Viral Vectors and Plasmid DNA Manufacturing Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2022-2027
Table 30. BioReliance Corporate Summary
Table 31. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 32. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 33. Cobra Biologics Corporate Summary
Table 34. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 35. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 36. Oxford BioMedica Corporate Summary
Table 37. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 38. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 39. UniQure Corporate Summary
Table 40. UniQure Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 41. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 42. FinVector Corporate Summary
Table 43. FinVector Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 44. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 45. MolMed Corporate Summary
Table 46. MolMed Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 47. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 48. MassBiologics Corporate Summary
Table 49. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 50. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 51. Richter-Helm Corporate Summary
Table 52. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 53. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 54. FUJIFILM Diosynth Biotechnologies Corporate Summary
Table 55. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 56. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 57. Lonza Corporate Summary
Table 58. Lonza Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 59. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 60. Aldevron Corporate Summary
Table 61. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 62. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 63. Eurogentec Corporate Summary
Table 64. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 65. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 66. Cell and Gene Therapy Catapult Corporate Summary
Table 67. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 68. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 69. Biovian Corporate Summary
Table 70. Biovian Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 71. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 72. Thermo Fisher Scientific (Brammer Bio) Corporate Summary
Table 73. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 74. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 75. VGXI Corporate Summary
Table 76. VGXI Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 77. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
Table 78. PlasmidFactory Corporate Summary
Table 79. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Offerings
Table 80. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Viral Vectors and Plasmid DNA Manufacturing Segment by Type
Figure 2. Viral Vectors and Plasmid DNA Manufacturing Segment by Application
Figure 3. Global Viral Vectors and Plasmid DNA Manufacturing Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Viral Vectors and Plasmid DNA Manufacturing Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2020
Figure 8. By Type - Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 9. By Application - Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 10. By Region - Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 11. By Country - North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 12. US Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 16. Germany Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 17. France Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 24. China Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 28. India Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 30. Brazil Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share, 2016-2027
Figure 33. Turkey Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Viral Vectors and Plasmid DNA Manufacturing Revenue, (US$, Mn), 2016-2027
Figure 37. BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 47. Aldevron Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 48. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 49. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 50. Biovian Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 51. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 52. VGXI Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 53. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs